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Presentation of Cases
Case 1
A ten-year-old girl with sickle cell disease
(SCD) (combined heterozygosity for the
abnormal hemoglobin S and abnormal
HbC; HbSC) presented to our clinic with
a history of four days fever, malaise, and a
generalized tonic-clonic convulsion. At pre-
sentation she was alert, nauseous, and
complained of headache and retro-orbital
pain. Temperature was 38.0uC, heart rate
(HR) 135/min, blood pressure (BP) 94/
62 mmHg, respiratory rate (RR) 20/min;
minor hepatosplenomegaly and upper-
quadrant abdominal tenderness were pres-
ent. No further abnormalities were reported
on physical examination. Initial lab results
revealed a moderate increase of CRP,
anemia, thrombocytopenia, prolonged acti-
vated partial thromboplastin time (aPTT)
and prothrombin time (PT), increased liver
enzymes, and decreased albumin and
hematocrit (Ht) (Table S1). On day two,
during defervescence she became hypoten-
sive and was treated with fluid resuscitation
and inotropic agents. Blood products were
transfused to correct anemia and thrombo-
cytopenia. Hemolysis and acute hemor-
rhage with gastrointestinal, vaginal, and
later on venipuncture sites bleeding devel-
oped. Splenic sequestration was also con-
sidered as the cause of anemia, but could
not be confirmed with abdominal ultra-
sound. Pleural effusion, gallbladder wall
thickening, and ascites were seen. On day
three, she lost vision. A brain CT scan
revealed no abnormalities. Lumbar punc-
ture was deferred and antibiotic treatment
was adjusted to cover possible meningitis.
Hereafter she developed acute respiratory
distress syndrome (ARDS) requiring me-
chanical ventilation. Dengue serology was
positive for IgM (titer: 3.26) and IgG (3.26)
(Focus Diagnostics), and RT-PCR showed
dengue virus serotype 2 (DENV-2). Her
clinical situation deteriorated with an in-
creased hemorrhagic tendency, and blood,
clotting products, and clotting factors were
administered. In time multiorgan dysfunc-
tion syndrome (MODS) developed. Blood
cultures remained negative for bacteria, but
antibiotics were administered anyway. Can-
dida was cultured and antifungals were
initiated. Despite intensive treatment the
patient did not recover, disseminated intra-
vascular coagulation (DIC) progressed and
kidney function did not return. Consequent-
ly further treatment was discontinued and
the patient died, 28 days after admission.
Case 2
A 19-year-old female presented to our
clinic with fever, headache, retro-orbital
pain, and muscle ache for two days. In
addition hematemesis and epistaxis started
on the day of admission. Her medical
history revealed sickle cell anemia (SCA)
(homozygosity for abnormal HbS; HbSS).
On examination she was alert, with a
temperature of 37uC, BP 120/80 mmHg,
HR 100/min, and RR 15–20/min. She
had right upper-quadrant abdominal ten-
derness. No other abnormalities on physical
examination were found. Initial lab results
revealed moderate increase of CRP, ane-
mia, thrombocytopenia, and increased liver
enzymes. NS1-antigen tested positive and
dengue serology was negative for IgM
(0.41) and positive for IgG (5.71), and
RT-PCR showed DENV-2. Shortly after
admittance she became hypotensive, with
distension of her abdomen. Intravenous
fluid resuscitation was started and further
intervention was implemented on the basis
of the monitoring of hematocrit, urine
output, and blood glucose. Profuse abdom-
inal bleeding was suspected, with marked
decrease of Hb, low platelets, severe
disrupted coagulation parameters, and
intra- and retro-abdominal free fluid with
fibrin strands on ultrasound. Moreover
extensive capillary leakage and anuria
developed. She was intubated due to
seizures and following sedation. Although
in the course of time shock and bleeding
stabilized, she continued to develop MODS
and both pupils became progressively less
reactive to light until nonreactive. CT brain
imaging could not be performed. On day
four, she died due to cardiac arrest.
No autopsies were performed on either
of the patients. Written informed consent
for publication of the disease histories was
obtained from the direct relatives of both
patients.
Case Discussion: Dengue and
Curac¸ao
During the past decades dengue has been
reported to occur in Curac¸ao. Until now
Citation: Moesker FM, Muskiet FD, Koeijers JJ, Fraaij PLA, Gerstenbluth I, et al. (2013) Fatal Dengue in Patients
with Sickle Cell Disease or Sickle Cell Anemia in Curac¸ao: Two Case Reports. PLoS Negl Trop Dis 7(8): e2203.
doi:10.1371/journal.pntd.0002203
Editor: Scott B. Halstead, Pediatric Dengue Vaccine Initiative, United States of America
Published August 8, 2013
Copyright:  2013 Moesker et al. This is an open-access article distributed under the terms of the Creative
Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium,
provided the original author and source are credited.
Funding: The work was funded by the Erasmus MC Rotterdam and by the Dutch government (project number
FES0908). The funders had no role in study design, data collection and analysis, decision to publish, or
preparation of the manuscript.
Competing Interests: We have read the journal’s policy and have the following conflicts: FMM’s, PLAF’s, and
ADMEO’s scientific work is supported by the Virgo consortium, funded by the Dutch government (project
number FES0908). In addition ADMEO has share certificates in ViroClinics Biosciences B.V. The majority of the
shares in ViroClinics Biosciences B.V. (.75%) are owned by Erasmus MC through its Erasmus MC Holding B.V.
To avoid any possible conflict of interest and to safeguard its employees against the possibility of unethical
decisions, the Erasmus MC does not allow any of its employees to hold shares in person in any companies that
are (partly) owned by Erasmus MC. As a result thereof, any shares provided by such companies to any Erasmus
MC employees are held by a Foundation Administration Office. The board of this foundation is appointed by
Erasmus MC. The employees receive share certificates of their shares. Apart form those described above the
authors have declared that no competing interests exist.
* E-mail: p.fraaij@erasmsumc.nl
PLOS Neglected Tropical Diseases | www.plosntds.org 1 August 2013 | Volume 7 | Issue 8 | e2203
fatal cases were never documented. Howev-
er the 2010–2011 outbreak with 1,822
serologically confirmed cases was associated
with four deaths (personal communication).
Two of these patients had been previously
diagnosed with SCD type HbSC and SCA.
SCD is not uncommon in Curac¸ao, with a
prevalence of approximately 0.25% [1].
Although chronic diseases such as SCD are
considered to be a risk factor for develop-
ment of severe dengue, few cases of children
or adolescents have been reported [2].
Literature Review
Both in the Americas and Asia all four
serotypes of DENV circulate with frequent
reports of fatal dengue. Until now no cases
of DENV infection in SCD patients have
been described in Asia, probably due to the
relatively low prevalence of SCD [3].
Furthermore reports describing patients
with this combination of diseases are scarce,
little-detailed, and restricted to a few fatal
cases apart from the Cuban study concern-
ing adults only (see Table 1) [4–10]. Bravo
et al. reported 158 fatal cases during the
1981 DENV-2 epidemic in Cuba (72
children and 26 adults) [8]. Eight patients
were suffering from sickle cell anemia, of
which five presented with hemorrhages and
three with shock. Half of them died within
24 hours after admission. The second
article from Cuba describes a DENV-3
outbreak in 2001 [4]. Two fatal cases with
HbSS and HbSC were reported. Both
patients presented with fever. In one
patient hemorrhage predominated, with
plasma leakage leading to shock in the
other case. Five or six days after admission,
both patients died. In 1999 Ware et al.
reported one fatal case of DHF in a SCA
patient [6]. She presented with bone pain
and fever, and she died four days after
admission. Most cases described are HbSS
patients. However none of the described
cases suggests treatment options or case
management, and interaction between
both diseases is not described.
Presented Cases and Treatment
Challenges
The clinical findings of the two cases
described here are difficult to interpret
because of the apparent complementary
vascular endothelial damage in SCD, SCA,
and severe dengue. As proposed in the model
of dengue pathogenesis by Martina et al.,
DENV might replicate in selective endothe-
liocytes [11]. In SCD, endothelial dysfunc-
tion is known to occur [12]. There is no
direct evidence from fatal dengue cases that
dengue virus replicates in endothelial cells.
Nonetheless, damage to endothelial cells as
reflected by increased vascular permeability
is central to the dengue vascular permeability
syndrome (DHF/DSS). Vascular endothelial
cells (VEC) play an important roll in
inflammation and coagulation. By damaging
the VEC either through infection of DENV
or by sickling of erythrocytes, the permeabil-
ity of the vascular endothelial layer can
increase, which may induce plasma leakage,
release of cytokines, and cause profound
shock. Based on these findings, we hypoth-
esize an essential role for endothelial cells to
contribute to disease severity. The similarities
between the cases are striking: shock, plasma
leakage, hemorrhage, and MODS [2].
However plasma leakage predominated in
case 1, whereas hemorrhage did in case 2.
The onset of vaso-occlusion with SCD and
SCA is often triggered by inflammation, as is
the case in a DENV infection [12]. Severe
bleeding seldom happens in children, but
only in cases of profound shock, and no
thrombotic complications are seen [13]. In
treating dengue patients with underlying
SCD or SCA, the treating physician is facing
a dilemma. In SCD and SCA, it is preferred
to maintain a low Ht to reduce the risk of
vaso-occlusion. Treating physicians may be
reluctant to perform blood transfusions in
SCD patients because of concerns of exces-
sive accumulation of iron, transfusion reac-
tions, and alloimmunization. However se-
vere anemia as a result of SCD or dengue
may necessitate blood transfusion. The
WHO reports an increase of Ht as a sign
of plasma leakage with subsequently a
decrease that may be due to hemorrhage.
Both cases showed a continuing decrease of
Ht, associated with hemorrhage with plasma
leakage also predominating, suggesting Ht
should not be used as a marker in patients
with SCD or SCA. Iatrogenic interstitial fluid
overload in patients with SCD, SCA, and
severe dengue, due to preexisting vascular
endothelial damage, is not just a theoretical
hazard. Whether the clinical manifestations
would just have been the result of secondary
DENV infection only, despite SCD or SCA,
remains a matter for debate. To further
address this issue, we suggest that a case-
control study should be performed to further
elucidate the proposed association between
severe dengue and SCD or SCA.
This report is based on two fatal cases of
severe dengue with underlying SCD/SCA
in Curac¸ao during the 2010–2011 epi-
demic. Currently no guidelines exist on
how to treat such patients. In populations
with a high prevalence of SCD, SCA, and
Table 1. Summary of literature review.
Author, year of publication Country
Number of
patients
Gender/age
(years)
SCD
type Dengue virus serotype Outcome
Present case 1 Curac¸ao 1 F/10 HbSC DENV-2 Died
Present case 2 Curac¸ao 1 F/19 HbSS DENV-2 Died
Limonta et al., 2009 Cuba 2 M/34
M/25
HbSC
HbSS
DENV-3 (s)
DENV-3 (s)
Died
Died
Andrianarisoa et al., 2007 Madagascar ND ND ND ND ND
Ware et al., 1999 Jamaica 1 F/19 HbSS ND Died
Teruel-Lo´pez et al., 1991** Venezuela ND ND ND ND ND
Bravo et al., 1987 Cuba 4
4
Adults
Children
HbSS
HbSS
DENV-2 (ND)
DENV-2 (ND)
Died
Died
Gentilini et al., 1964* Haiti ND ND ND ND ND
M, male; F, female; ND, no data available; DENV, dengue virus serotype; (s), secondary; HbSC, heterozygote sickle cell disease; HbSS, homozygote sickle cell anemia;
HbAS, sickle cell trait;
*no abstract available;
**review describing Bravo et al. article.
doi:10.1371/journal.pntd.0002203.t001
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dengue activity, clinicians should be aware
of the challenges in clinical management.
Supporting Information
Table S1 Detailed laboratory data of
both patients.
(DOC)
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Learning Points
1) This case report is suggestive of a fatal interaction between dengue and sickle
cell disease or sickle cell anemia.
2) Hematocrit values are of limited use for treatment decisions in patients with
severe dengue infection and sickle cell disease or sickle cell anemia.
PLOS Neglected Tropical Diseases | www.plosntds.org 3 August 2013 | Volume 7 | Issue 8 | e2203
